secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2022-03-28T23:59:59+00:00
Accession:  0001683168-22-001999
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cannabics Pharmaceuticals changes name to CNBX Pharmaceuticals, ticker unchanged
--------------------------------------------------------------------------------

- Name change effective March 28, 2022; stock continues trading on OTCQB under symbol CNBX.
- Name change reflects transformation to molecule-based drug development for colorectal cancer treatment.
- Company preparing Phase I/II clinical validation study for proprietary RCC-33 drug candidate.
- Stockholders need not exchange certificates; rights unaffected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316822001999/0001683168-22-001999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316822001999/cannabics_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-001999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer